Organon & (US:OGN) GlobeNewswire News Roomยท2025-06-13 17:10Core Viewpoint - Organon & Co. is facing a class action lawsuit due to significant changes in its dividend policy and alleged misleading statements regarding its financial health and business strategy [1][3]. Financial Performance - On May 1, 2025, Organon reported its Q1 2025 financial results, announcing a drastic reduction in its dividend payout from $0.28 to $0.02, reallocating funds towards debt reduction [2]. - Following this announcement, Organon's stock price dropped by $3.48, or 26.9%, closing at $9.45 per share on the same day [2]. Lawsuit Details - The class action complaint alleges that during the Class Period, Organon made materially false and misleading statements and failed to disclose adverse facts about its business and operations [3]. - Specific allegations include the misleading portrayal of the dividend payout as a priority while simultaneously implementing a debt reduction strategy that led to a more than 70% decrease in the quarterly dividend [3]. - The lawsuit claims that the positive statements made by the company regarding its business prospects lacked a reasonable basis and were materially misleading [3]. Legal Action - Investors who purchased Organon securities during the Class Period have until July 22, 2025, to file a lead plaintiff motion in the class action lawsuit [1][4].